Extended International Normalized Ratio testing intervals for warfarin-treated patients

Barriers and facilitators to reducing frequent laboratory testing for patients who are stable on warfarin: a mixed methods study of de-implementation in five anticoagulation clinics

(2017) Geoffrey D. Barnes et al.   Implementation Science

Stability of International Normalized Ratios in Patients Taking Long-term Warfarin Therapy

(2016) Sean D. Pokorney et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter

(2016) Paul A. Heidenreich et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of an extended INR follow-up interval for Veteran patients in an anticoagulation clinic

(2016) Andrea L. Porter et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH

(2015) S. Kaatz et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The Predictive Ability of the CHADS2 and CHA2DS2-VASc Scores for Bleeding Risk in Atrial Fibrillation: The MAQI2 Experience

(2014) Geoffrey D. Barnes et al.   THROMBOSIS RESEARCH

Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios

(2013) Sam Schulman et al.   ANNALS OF INTERNAL MEDICINE

Evidence-Based Management of Anticoagulant Therapy

(2012) Anne Holbrook et al.   CHEST

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST